Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Development of new in vitro methods for frontloading of reproductive toxicology in drug development
| Reference number | 2008-00139 |
| Coordinator | AstraZeneca AB - AstraZeneca R&D Södertälje |
| Funding from Vinnova | SEK 4 050 000 |
| Project duration | August 2008 - March 2012 |
| Status | Completed |
Last updated 25 November 2019
Reference number 2008-00139
